Data from the phase 2 ROME trial were presented by Andrea Botticelli, MD, during the ESMO Targeted Anticancer Therapies ...

The FDA has approved new agents in ovarian cancer and non–small cell lung cancer and paved the way for novel antibody-drug conjugate developments.

For ovarian cysts that cause pain, medications such as acetaminophen, ibuprofen, or another non-steroidal anti-inflammatory ...

To address this challenge, CTMC has established a patient material bank, enabling early-stage process development with clinically relevant samples. This resource also supports continuous process ...

It took almost a decade for Aliza Lynch to confirm she had endometriosis despite living with crippling pain that was so bad ...

We are actively recruiting the Phase 1 trial of OP-3136 in multiple solid tumor types ... demonstrated anti-tumor activity in in vivo xenograft models of ovarian (OVCAR3), NSCLC (LCLC-97TM1 ...

The U.S. Federal Drug Administration (FDA) has granted Incyclix Bio Fast Track designation for INX-315 to treat ...

demonstrates the potential of K-TRACK TM in monitoring treatment response and assessing recurrence risk among 623 Solid-Tumor ...

In solid tumors, such as skin ... PRAME is produced by many tumors, such as melanoma, ovarian cancer, sarcomas, and lung cancer. A good half of the people treated who had not responded to standard ...

Activity in preclinical models of ovarian, prostate ... 3136 as a monotherapy and in combination regimens in multiple solid tumor types Data to be presented at 2025 AACR Annual Meeting SAN ...

Alan Trounson says endometriosis and ovarian cancer are two critical women’s health issues. Companies like Cartherics are developing complex therapies that can effectively target solid tumours ...